# On Semiconductor Corp: financial statements, quarterly ON · Nasdaq · CIK 1097864 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/on.md) · [Financials](/companies/on/financials.md) · [Filings](/companies/on/filings.md) · [Insiders](/companies/on/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/on/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [2,181](/filings/0001628280-24-043880.md) | [2,018 d](/filings/0001097864-26-000006.md) | [1,863](/filings/0001628280-25-022042.md) | [1,735](/filings/0001097864-25-000013.md) | [1,762](/filings/0001097864-25-000019.md) | [1,723 d](/filings/0001097864-26-000006.md) | [1,446](/filings/0001097864-26-000014.md) | [1,469](/filings/0001097864-26-000017.md) | [1,551](/filings/0001097864-25-000019.md) | [1,530 d](/filings/0001097864-26-000006.md) | [1,513](/filings/0001097864-26-000014.md) | [1,604](/filings/0001097864-26-000017.md) | | Cost of revenue | $m | [1,150](/filings/0001628280-24-043880.md) | [1,076 d](/filings/0001097864-26-000006.md) | [1,009](/filings/0001628280-25-022042.md) | [951](/filings/0001097864-25-000013.md) | [963](/filings/0001097864-25-000019.md) | [943 d](/filings/0001097864-26-000006.md) | [1,152](/filings/0001097864-26-000014.md) | [917](/filings/0001097864-26-000017.md) | [964](/filings/0001097864-25-000019.md) | [979 d](/filings/0001097864-26-000006.md) | [930](/filings/0001097864-26-000014.md) | [987](/filings/0001097864-26-000017.md) | | Gross profit | $m | [1,031](/filings/0001628280-24-043880.md) | [942 d](/filings/0001097864-26-000006.md) | [854](/filings/0001628280-25-022042.md) | [784](/filings/0001097864-25-000013.md) | [799](/filings/0001097864-25-000019.md) | [779 d](/filings/0001097864-26-000006.md) | [294](/filings/0001097864-26-000014.md) | [552](/filings/0001097864-26-000017.md) | [587](/filings/0001097864-25-000019.md) | [551 d](/filings/0001097864-26-000006.md) | [583](/filings/0001097864-26-000014.md) | [616](/filings/0001097864-26-000017.md) | | Operating income | $m | [687](/filings/0001628280-24-043880.md) | [612 d](/filings/0001097864-26-000006.md) | [525](/filings/0001628280-25-022042.md) | [389](/filings/0001097864-25-000013.md) | [445](/filings/0001097864-25-000019.md) | [409 d](/filings/0001097864-26-000006.md) | [(574)](/filings/0001097864-26-000014.md) | [193](/filings/0001097864-26-000017.md) | [264](/filings/0001097864-25-000019.md) | [200 d](/filings/0001097864-26-000006.md) | [(53.4)](/filings/0001097864-26-000014.md) | [259](/filings/0001097864-26-000017.md) | | Interest expense | $m | [16.2](/filings/0001628280-23-035450.md) | [15.8 d](/filings/0001628280-24-003201.md) | [15.6](/filings/0001628280-24-018814.md) | [15.7](/filings/0001097864-25-000013.md) | [15.7](/filings/0001097864-25-000019.md) | [15.3 d](/filings/0001097864-26-000006.md) | [18.0](/filings/0001097864-26-000014.md) | [17.9](/filings/0001097864-26-000017.md) | [17.7](/filings/0001097864-25-000019.md) | [17.3 d](/filings/0001097864-26-000006.md) | [12.7](/filings/0001097864-26-000014.md) | [13.7](/filings/0001097864-26-000017.md) | | Income tax | $m | [115](/filings/0001628280-24-043880.md) | [47.5 d](/filings/0001097864-26-000006.md) | [84.5](/filings/0001628280-25-022042.md) | [63.7](/filings/0001097864-25-000013.md) | [51.9](/filings/0001097864-25-000019.md) | [62.7 d](/filings/0001097864-26-000006.md) | [(75.8)](/filings/0001097864-26-000014.md) | [30.5](/filings/0001097864-26-000017.md) | [17.7](/filings/0001097864-25-000019.md) | [35.3 d](/filings/0001097864-26-000006.md) | [(11.7)](/filings/0001097864-26-000014.md) | [43.4](/filings/0001097864-26-000017.md) | | Net income | $m | [583](/filings/0001628280-24-043880.md) | [563 d](/filings/0001097864-26-000006.md) | [453](/filings/0001628280-25-022042.md) | [338](/filings/0001097864-25-000013.md) | [402](/filings/0001097864-25-000019.md) | [380 d](/filings/0001097864-26-000006.md) | [(486)](/filings/0001097864-26-000014.md) | [170](/filings/0001097864-26-000017.md) | [255](/filings/0001097864-25-000019.md) | [182 d](/filings/0001097864-26-000006.md) | [(33.4)](/filings/0001097864-26-000014.md) | [227](/filings/0001097864-26-000017.md) | | Diluted EPS | $ per share | [1.29](/filings/0001628280-24-043880.md) | not reported | [1.04](/filings/0001628280-25-022042.md) | [0.78](/filings/0001097864-25-000013.md) | [0.93](/filings/0001097864-25-000019.md) | not reported | [(1.15)](/filings/0001097864-26-000014.md) | [0.41](/filings/0001097864-26-000017.md) | [0.63](/filings/0001097864-25-000019.md) | not reported | [(0.08)](/filings/0001097864-26-000014.md) | [0.56](/filings/0001097864-26-000017.md) | | Basic EPS | $ per share | [1.35](/filings/0001628280-24-043880.md) | not reported | [1.06](/filings/0001628280-25-022042.md) | [0.79](/filings/0001097864-25-000013.md) | [0.94](/filings/0001097864-25-000019.md) | not reported | [(1.15)](/filings/0001097864-26-000014.md) | [0.41](/filings/0001097864-26-000017.md) | [0.63](/filings/0001097864-25-000019.md) | not reported | [(0.08)](/filings/0001097864-26-000014.md) | [0.58](/filings/0001097864-26-000017.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-29) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | FY2024 (2024-12-31) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [2.7](/filings/0001628280-24-043880.md) | [2.5](/filings/0001097864-26-000006.md) | [2.6](/filings/0001628280-25-022042.md) | [2.2](/filings/0001097864-25-000013.md) | [2.5](/filings/0001097864-25-000019.md) | [2.7](/filings/0001097864-26-000017.md) | [2.8](/filings/0001097864-26-000014.md) | [2.5](/filings/0001097864-26-000017.md) | [2.5](/filings/0001097864-25-000019.md) | [2.1](/filings/0001097864-26-000017.md) | [2.0](/filings/0001097864-26-000014.md) | [3.5](/filings/0001097864-26-000017.md) | | Current assets | $bn | [6.1](/filings/0001628280-23-035450.md) | [5.9](/filings/0001628280-25-004557.md) | [6.1](/filings/0001628280-24-018814.md) | [6.3](/filings/0001628280-24-033229.md) | [6.5](/filings/0001628280-24-043880.md) | [6.8](/filings/0001097864-26-000006.md) | [6.3](/filings/0001628280-25-022042.md) | [6.4](/filings/0001097864-25-000013.md) | [6.3](/filings/0001097864-25-000019.md) | [5.8](/filings/0001097864-26-000017.md) | [5.8](/filings/0001097864-26-000014.md) | [7.3](/filings/0001097864-26-000017.md) | | Total assets | $bn | [13.3](/filings/0001628280-23-035450.md) | [13.2](/filings/0001628280-25-004557.md) | [13.5](/filings/0001628280-24-018814.md) | [13.7](/filings/0001628280-24-033229.md) | [13.9](/filings/0001628280-24-043880.md) | [14.1](/filings/0001097864-26-000006.md) | [13.3](/filings/0001628280-25-022042.md) | [13.1](/filings/0001097864-25-000013.md) | [13.0](/filings/0001097864-25-000019.md) | [12.5](/filings/0001097864-26-000017.md) | [12.0](/filings/0001097864-26-000014.md) | [13.5](/filings/0001097864-26-000017.md) | | Current liabilities | $bn | [2.5](/filings/0001628280-23-035450.md) | [2.2](/filings/0001628280-25-004557.md) | [2.1](/filings/0001628280-24-018814.md) | [2.1](/filings/0001628280-24-033229.md) | [2.1](/filings/0001628280-24-043880.md) | [1.3](/filings/0001097864-26-000006.md) | [1.3](/filings/0001628280-25-022042.md) | [1.3](/filings/0001097864-25-000013.md) | [1.2](/filings/0001097864-25-000019.md) | [1.3](/filings/0001097864-26-000017.md) | [1.2](/filings/0001097864-26-000014.md) | [2.1](/filings/0001097864-26-000017.md) | | Total liabilities | $bn | [5.8](/filings/0001628280-23-035450.md) | [5.4](/filings/0001628280-25-004557.md) | [5.3](/filings/0001628280-24-018814.md) | [5.3](/filings/0001628280-24-033229.md) | [5.3](/filings/0001628280-24-043880.md) | [5.3](/filings/0001097864-26-000006.md) | [5.2](/filings/0001628280-25-022042.md) | [5.2](/filings/0001097864-25-000013.md) | [5.1](/filings/0001097864-25-000019.md) | [4.8](/filings/0001097864-26-000017.md) | [4.7](/filings/0001097864-26-000014.md) | [6.2](/filings/0001097864-26-000017.md) | | Long-term debt | $bn | [2.5](/filings/0001628280-23-035450.md) | [2.5](/filings/0001628280-25-004557.md) | [2.5](/filings/0001628280-24-018814.md) | [2.5](/filings/0001628280-24-033229.md) | [2.5](/filings/0001628280-24-043880.md) | [3.3](/filings/0001097864-26-000006.md) | [3.3](/filings/0001628280-25-022042.md) | [3.4](/filings/0001097864-25-000013.md) | [3.4](/filings/0001097864-25-000019.md) | [3.0](/filings/0001097864-26-000017.md) | [3.0](/filings/0001097864-26-000014.md) | [3.7](/filings/0001097864-26-000017.md) | | Current portion of debt | $bn | [0.9](/filings/0001628280-23-035450.md) | [0.8](/filings/0001628280-25-004557.md) | [0.8](/filings/0001628280-24-018814.md) | [0.8](/filings/0001628280-24-033229.md) | [0.8](/filings/0001628280-24-043880.md) | [0.0](/filings/0001628280-25-004557.md) | not reported | not reported | not reported | [0.0](/filings/0001097864-26-000017.md) | not reported | [0.8](/filings/0001097864-26-000017.md) | | Shareholders' equity | $bn | [7.5](/filings/0001628280-23-035450.md) | [7.8](/filings/0001628280-25-004557.md) | [8.1](/filings/0001628280-24-018814.md) | [8.3](/filings/0001628280-24-033229.md) | [8.6](/filings/0001628280-24-043880.md) | [8.8](/filings/0001097864-26-000006.md) | [8.0](/filings/0001628280-25-022042.md) | [7.9](/filings/0001097864-25-000013.md) | [7.9](/filings/0001097864-25-000019.md) | [7.7](/filings/0001097864-26-000017.md) | [7.3](/filings/0001097864-26-000014.md) | [7.2](/filings/0001097864-26-000017.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [567 d](/filings/0001628280-24-043880.md) | [611 d](/filings/0001097864-26-000006.md) | [499](/filings/0001628280-25-022042.md) | [362 d](/filings/0001097864-25-000013.md) | [466 d](/filings/0001097864-25-000019.md) | [580 d](/filings/0001097864-26-000006.md) | [602](/filings/0001097864-26-000014.md) | [184 d](/filings/0001097864-26-000017.md) | [419 d](/filings/0001097864-25-000019.md) | [555 d](/filings/0001097864-26-000006.md) | [239](/filings/0001097864-26-000014.md) | [460 d](/filings/0001097864-26-000017.md) | | Capital expenditure | $m | [433 d](/filings/0001628280-24-043880.md) | [354 d](/filings/0001097864-26-000006.md) | [234](/filings/0001628280-25-022042.md) | [141 d](/filings/0001097864-25-000013.md) | [162 d](/filings/0001097864-25-000019.md) | [157 d](/filings/0001097864-26-000006.md) | [148](/filings/0001097864-26-000014.md) | [78.2 d](/filings/0001097864-26-000017.md) | [46.3 d](/filings/0001097864-25-000019.md) | [69.1 d](/filings/0001097864-26-000006.md) | [21.9](/filings/0001097864-26-000014.md) | [34.3 d](/filings/0001097864-26-000017.md) | | Share repurchases | $m | [99.9 d](/filings/0001628280-24-043880.md) | [300 d](/filings/0001097864-26-000006.md) | [100](/filings/0001628280-25-022042.md) | [150 d](/filings/0001097864-25-000013.md) | [200 d](/filings/0001097864-25-000019.md) | [204 d](/filings/0001097864-26-000006.md) | [300](/filings/0001097864-26-000014.md) | [302 d](/filings/0001097864-26-000017.md) | [325 d](/filings/0001097864-25-000019.md) | [450 d](/filings/0001097864-26-000006.md) | [346](/filings/0001097864-26-000014.md) | [345 d](/filings/0001097864-26-000017.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [449](/filings/0001628280-23-035450.md) | [449](/filings/0001628280-24-018814.md) | [449](/filings/0001628280-24-033229.md) | [451](/filings/0001628280-24-043880.md) | [437](/filings/0001628280-25-022042.md) | [433](/filings/0001097864-25-000013.md) | [432](/filings/0001097864-25-000019.md) | [421](/filings/0001097864-26-000014.md) | [415](/filings/0001097864-26-000017.md) | [408](/filings/0001097864-25-000019.md) | [394](/filings/0001097864-26-000014.md) | [404](/filings/0001097864-26-000017.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 389,311,721 at 2026-07-29, from the cover of the [10-Q filed 2026-08-03](/filings/0001097864-26-000017.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.